| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=0.01uM, N-(5-(1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyramide, LIM kinase-1 inhibitor;LIM kinase-2 inhibitor targeting LIMK1, LIMK2 (Novartis, 56965901) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/56965901 |
| Similar Terms | |
| Downloads & Tools |
1 genes differentially expressed following the BC-56-BB82_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|
| Symbol | Name | Standardized Value |
|---|---|---|
| CCDC93 | coiled-coil domain containing 93 | -0.371583 |